Miguel Quintela-Fandino

13PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersBioinformatic methods developmentMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 17, 2026
Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.

|Feb 18, 2026
The automated computational workflow QUICHE reveals structural definitions of antitumor responses in triple-negative breast cancer.

Jolene S Ranek, Noah F Greenwald, Mako Goldston

|Sep 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer.

Luis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra

|Jun 23, 2025
Predicting resistance to chemotherapy using chromosomal instability signatures.

Joe Sneath Thompson, Laura Madrid, Barbara Hernando

|Apr 02, 2025
The impact of a high fat diet and platelet activation on pre-metastatic niche formation.

Marta Hergueta-Redondo, Sara Sánchez-Redondo, Begoña Hurtado

|Sep 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora

Pageof 3

Frequent Collaborators

3 joint publications

Maria J Bueno

3 joint publications

Luis Manso

3 joint publications

José Ángel García-Saenz

2 joint publications

Javier Cortés